Both in Pharmaceuticals
Celularity vs Aardvark Therapeutics
Over the past year CELU returned −53.2% and AARD returned −88.1%; their daily moves had a correlation of 0.14.
CELU −53.2% AARD −88.1%Growth of $1, one year, split-adjusted
| Metric | CELU | AARD |
|---|---|---|
| Price | $0.8042 | $1.24 |
| Market cap | $26.1M | $27.0M |
| Today | +0.21% | +2.92% |
| 1 month | −53.0% | −76.3% |
| 6 months | −15.6% | −77.4% |
| Year to date | −27.5% | −90.6% |
| 1 year | −58.8% | −88.4% |
| Revenue growth (YoY) | −5.3% | — |
| Gross margin | 56.8% | — |
| Net margin | 10.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.4× | — |
| Net cash | -$37.1M | $73.9M |
| Dividend yield | — | — |
| Volatility (60d) | 223.1% | 240.9% |
| Short % of float | 6.7% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).